Drug regulator through executive order issued last August paved way for direct launch of certain categories of drugs approved in select countries by means of local clinical trials waiver.
Following December notice prohibiting combination of chlorpheniramine maleate & phenylephrine hydrochloride, CDSCO has ‘decided to rope in paediatricians to review other permitted FDCs’.
India's apex drug regulator will form a panel to examine whether more regulatory restrictions should be put in place. Experts say more curbs a good idea but implementation is key.
China and India are home to 1.2 billion young people. They’re the pioneers in advancing the rejuvenation of the Chinese nation and realising the vision of ‘Viksit Bharat 2047’.
The countries signed a memorandum for co-development of UNICORN masts in November 2024. India has been second Asian nation to have such an agreement with Tokyo, after Philippines.
COMMENTS